Results

Total Results: 460 records

Showing results for "vascular".

441. Pbt-Lsr-Draft-Ets-Rcts (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-rcts.xlsx
     March 15, 2022 - 0 118 0 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Memory impairment, infections, vascular

442. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0.xlsx
     February 16, 2022 - 0 118 0 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Memory impairment, infections, vascular

443. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
     January 01, 2022 - 0 118 0 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Memory impairment, infections, vascular

444. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
     January 01, 2022 - 0 118 0 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Memory impairment, infections, vascular

445. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
     February 16, 2022 - 0 118 0 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Memory impairment, infections, vascular

446. Methods-Guidance-Reporting-Bias Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
     November 01, 2013 - signal of reporting bias.111 A common example in cardiovascular research is the composite outcome of vascular

447. Renal-Function Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
     August 01, 2014 - that adjusted for age and CAD and/or similar risk equivalent (cerebrovascular disease, peripheral vascular

448. Stakeholder-Engagement-Benefits White-Paper (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement-benefits_white-paper.pdf
     March 01, 2014 - Vice President of Health Economics, Policy and Payment Medtronic Cardiac and Vascular Group Santa

449. Cannabis-Annual-Update2-Table-E1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e1.xlsx
     March 13, 2023 - NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Memory impairment, infections, vascular

450. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
     January 01, 2022 - NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Memory impairment, infections, vascular

451. Draft-Living-Review-Plant-Chronic-Pain-E-Evidence-Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-evidence-tables.xlsx
     March 25, 2024 - NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Memory impairment, infections, vascular

452. People-With-Disabilities-Draft-Report-App-E-F (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/people-with-disabilities-draft-report-app-e-f.xlsx
     January 01, 2022 - 65 with a diagnosis of cognitive impairment Diagnosis of Alzheimer’s disease, mixed-type dementia vascular

453. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
     January 01, 2022 - NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Memory impairment, infections, vascular

454. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
     January 01, 2023 - NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Memory impairment, infections, vascular

455. Cannabis-2023-Surv-Rep-1-App-F (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
     January 01, 2023 - NR NR NR NR NA NA NA NA NA NA NR NR NR NR NR NR NR NA NA NA NA NA NA Memory impairment, infections, vascular

456. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast

457. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - program include a home health care team, a defined protocol with careful patient selection, good vascular

458. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - Vitamin D Replacement During Winter Months in Patients With Hypertension #107 is Effect of Vitamin D3 on Vascular

459. Medicare Prescription Drug Data Development: Methods for Improving Patient Safety and Pharmacovigilance Using Observational Data | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/patient-safety-databases-prescriptions/research
     August 26, 2008 - disease 24 PULMCIRC Num 3 Pulmonary circulation disease 25 PERIVASC Num 3 Peripheral vascular

460. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
     March 01, 2011 - nephrogenic systemic fibrosis, contrast-related harms, adverse reactions to drugs for stress tests, vascular